Amplia Therapeutics (ASX:ATX) Ending Cash Position : A$5.66 Mil (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Amplia Therapeutics Ending Cash Position?

Amplia Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2023 was A$5.66 Mil.

Amplia Therapeutics's quarterly Ending Cash Position declined from Sep. 2022 (A$11.68 Mil) to Mar. 2023 (A$9.26 Mil) and declined from Mar. 2023 (A$9.26 Mil) to Sep. 2023 (A$5.66 Mil).

Amplia Therapeutics's annual Ending Cash Position increased from Mar. 2021 (A$1.85 Mil) to Mar. 2022 (A$14.61 Mil) but then declined from Mar. 2022 (A$14.61 Mil) to Mar. 2023 (A$9.26 Mil).

Amplia Therapeutics Ending Cash Position Historical Data

The historical data trend for Amplia Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplia Therapeutics Ending Cash Position Chart

Amplia Therapeutics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Ending Cash Position

Get a 7-Day Free Trial

1.11

1.85

14.61

9.26

3.39

Amplia Therapeutics Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															14.61	11.68	9.26	5.66	3.39

Amplia Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amplia Therapeutics's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14.609	+	-5.352
	=	9.26

Amplia Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	9.258	+	-3.601
	=	5.66

Amplia Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amplia Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amplia Therapeutics (ASX:ATX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amplia Therapeutics Ltd (ASX:ATX) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

INNMF:USA

Address

350 Queen Street, Level 17, Melbourne, VIC, AUS, 3000

Website

https://www.ampliatx.com

Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.

Amplia Therapeutics (ASX:ATX) Headlines

No Headlines